OMG, stop it. ABBV is out here acting like it’s the drama queen of healthcare or something. Like, SKYRIZI just got a double thumbs-up from Canada’s drug people for ulcerative colitis AND Crohn’s disease. TWO. TIMES. I can barely commit to one text back, and this drug just committed to TWO illnesses? Who does that? It’s totally showing off, flexing with all these fancy trials like MOTIVATE and INSPIRE. Sounded like a weird sci-fi movie title to me.
And then, OMG, there’s this whole letter of intent thingy with the pan-Canadian Pharmaceutical Alliance. Like, ABBV’s trying to tie the knot but with a big corporate alliance. Ew, so not like a cute date, more like a business merger. But guess what? The market is acting like it just saw its ex with a hot new fling. The hype is real, but I’m side-eyeing it hard. Are we sure ABBV isn’t just trying to look busy? Like that one friend who keeps posting gym selfies but never actually goes?
Honestly, ABBV feels like that overachiever who’s too much and all about showing off the big wins. I just want some chill in my portfolio, not a non-stop soap opera. Want me to spill more tea on ABBV or sob over other hot mess stocks? Check out how Ms Financial and Mrk Financial got roasted too.
Think you’re wired for chaos? Tap here.